New nanoparticles can perform gene editing in the lungs

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

An Interview with Colossal Biosciences CEO Ben Lamm

Genome editing via non-viral delivery platforms: current progress

Lung Cancer Detection via Inhalable Nanosensors, Paper-Based Urine

RTI Newsroom

Oscar R. Miranda, PhD/MBA/BE (He/Him) on LinkedIn: New

Exploring nano-enabled CRISPR-Cas-powered strategies for efficient

Specialized Nanoparticles Create a “Breath Signal” to Diagnose

April Bulletin — The Marble Center for Cancer Nanomedicine

Developing a new cure for lung cancer with mRNA technology

Serene Forte, PhD, MPH on LinkedIn: New nanoparticles can perform

Rajith S Manan (@MananRajith) / X

Gene Editing Shows Potential for Cystic Fibrosis

RNA, MIT News